FDA Approves Wellaho Mobile Monitoring Platform

| Printer friendly version

Sanitas, Inc., announced today that it received approval from the United States Food and Drug Administration for its Wellaho system.  According to its press release, Wellaho’s Personalized Outpatient Management System™ has been approved as a 510(K) class II medical device.  The press release states that the Wellaho system is a web-based and mobile platform that allows providers a secure, HIPAA compliant tool to supervise and monitor patients with chronic conditions between office visits.

The CEO of Sanitas, Inc. states:

Patients with chronic conditions need a web of care, coming from the best that providers and technology can offer. Given the tsunami of new apps and technologies that hit the market each year, both patients and providers need the highest validation for the products and services they use. Now, with the FDA’s approval, Wellaho offers one more reason for providers and patients to trust that we can provide a safe, secure, and effective solution for managing their care.

According to the press release, the Wellaho system is currently deployed in clinical studies at UC San Diego Health Services.  Sanitas, Inc.’s press release is available through PRNewswire here.

Leave a Reply

By using this blog, you agree and understand that no information is being provided in the context of any attorney-client relationship. You further agree and understand that nothing herein is intended to be legal advice. This blog is solely informational in nature, and is not intended as, and should not be used as, a substitute for competent legal advice from a retained and licensed attorney in your state. Knobbe Martens LLP makes no representations or warranties as to the accuracy, completeness, timeliness or availability of the information in this blog. Knobbe Martens LLP will not be liable for any injury or damages relating to your use of, or access to, any such information. Knobbe Martens LLP undertakes no obligation to correct or update information on this blog, which may be incorrect or become incorrect or out of date over time. Knobbe Martens LLP reserves the right to alter or delete content or information on the blog at any time. This blog contains links and references to other websites and publications that you may find of interest. Knobbe Martens LLP does not control, promote, endorse or otherwise have any affiliation with any other websites or publications unless those websites or publications expressly state such an affiliation. Knobbe Martens LLP further has no responsibility for, and makes no representations regarding, the content, accuracy or any other aspect of the information in such websites or publications.